- Legend Biotech CEO abruptly steps down without permanent replacementIn a sudden leadership shift, Legend Biotech announced that its CEO, Ying Huang, Ph.D., resigned on Friday, with no permanent replacement yet named.Fierce Biotech · 13h ago↗ source
- From confidence to capital: Positioning biotech for the next growth cycle<p>How can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.</p>BioPharma Dive · 13h ago↗ source
- Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drugArgenx is spending $2.2 billion to absorb Forte Biosciences for its phase 2-stage vitiligo and celiac disease drug.Fierce Biotech · 16h ago↗ source